All Stories

  1. NOVA1 acts as an oncogenic RNA-binding protein to regulate cholesterol homeostasis in human glioblastoma cells
  2. DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2
  3. Dendritic cell vaccines containing lymphocytes produce improved immunogenicity in patients with cancer
  4. Loss of the multifunctional RNA-binding protein RBM47 as a source of selectable metastatic traits in breast cancer
  5. Mapping Argonaute and conventional RNA-binding protein interactions with RNA at single-nucleotide resolution using HITS-CLIP and CIMS analysis
  6. RNA Protein Interaction in Neurons
  7. Ri/Nova gene-associated paraneoplastic subacute motor neuronopathy
  8. Dendritic cells loaded with FK506 kill T cells in an antigen-specific manner and prevent autoimmunity in vivo
  9. NOVA-dependent regulation of cryptic NMD exons controls synaptic protein levels after seizure
  10. Paraneoplastic Syndromes (Contemporary Neurology Series)
  11. Cellular Immune Suppression in Paraneoplastic Neurologic Syndromes Targeting Intracellular Antigens
  12. Neuronal Elav-like (Hu) Proteins Regulate RNA Splicing and Abundance to Control Glutamate Levels and Neuronal Excitability
  13. The George C. Cotzias Lecturer: Robert B. Darnell, D, PhD: Neurology Collides with the RNA World – From Intellectual Disability to Motor Neuron Disease
  14. De Novo Gene Disruptions in Children on the Autistic Spectrum
  15. An alternative mode of microRNA target recognition
  16. The maintenance of Purkinje axons by an RNA-binding protein HuC in adult cerebellum
  17. FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism
  18. Protein-RNA and Protein-Protein Recognition by Dual KH1/2 Domains of the Neuronal Splicing Factor Nova-1
  19. Structure-function studies of FMRP RGG peptide recognition of an RNA duplex-quadruplex junction
  20. Mapping in vivo protein-RNA interactions at single-nucleotide resolution from HITS-CLIP data
  21. The neuronal splicing factor Nova controls alternative splicing in N-type and P-type CaV2 calcium channels
  22. RNA regulation in Neurodegeneration and Cancer
  23. Faculty Opinions recommendation of Transmembrane receptor DCC associates with protein synthesis machinery and regulates translation.
  24. HITS‐CLIP: panoramic views of protein–RNA regulation in living cells
  25. Nova2 Regulates Neuronal Migration through an RNA Switch in Disabled-1 Signaling
  26. The Onconeural Antigen cdr2 Is a Novel APC/C Target that Acts in Mitosis to Regulate C-Myc Target Genes in Mammalian Tumor Cells
  27. Paraneoplastic Syndromes
  28. Pathogenesis
  29. Paraneoplastic Antinuclear and Antinucleolar Antibodies
  30. Synaptic and Channel Antibodies
  31. Cytoplasmic Antibodies
  32. Cerebral Hemisphere Syndromes
  33. Brainstem and Cerebellum
  34. Spinal Cord Syndromes
  35. Neuromuscular Junction and Muscle
  36. Clinical Findings, Diagnosis, Treatment, and Prognosis
  37. Anti-Retinal and Optic Nerve Antibodies
  38. Hematologic Malignancies and Miscellaneous Solid Tumors
  39. Faculty Opinions recommendation of Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy.
  40. RNA processing and its regulation: global insights into biological networks
  41. RNA Regulation in Neurologic Disease and Cancer
  42. The maintenance of Purkinje axons by HuC in adult cerebellum
  43. A Mouse Model of the Human Fragile X Syndrome I304N Mutation
  44. Autoimmune encephalopathy: The spectrum widens
  45. Argonaute HITS-CLIP decodes microRNA–mRNA interaction maps
  46. Tolerance to the Neuron-Specific Paraneoplastic HuD Antigen
  47. HITS-CLIP yields genome-wide insights into brain alternative RNA processing
  48. F.16. Identification of HuD-specific CD8+ T Cells in Paraneoplastic Neurologic Degeneration Patients with Tumor Immunity and Autoimmunity
  49. CLIP: Crosslinking and ImmunoPrecipitation of In Vivo RNA Targets of RNA-Binding Proteins
  50. Evolution of Nova-Dependent Splicing Regulation in the Brain
  51. NMDA receptor as a target in paraneoplastic encephalitis
  52. Functional and Mechanistic Insights From Genome-Wide Studies of Splicing Regulation in the Brain
  53. An RNA map predicting Nova-dependent splicing regulation
  54. Paraneoplastic Syndromes Affecting the Nervous System
  55. RNA binding proteins and the regulation of neuronal synaptic plasticity
  56. CLIP: A method for identifying protein–RNA interaction sites in living cells
  57. Common Molecular Pathways Mediate Long-Term Potentiation of Synaptic Excitation and Slow Synaptic Inhibition
  58. A new cause of limbic encephalopathy
  59. Apoptotic Cells Deliver Processed Antigen to Dendritic Cells for Cross-Presentation
  60. Nova autoregulation reveals dual functions in neuronal splicing
  61. Neuroimmunology of the paraneoplastic neurological degenerations
  62. Sox21 is a repressor of neuronal differentiation and is antagonized by YB-1
  63. The fragile X mental retardation protein, FMRP, recognizes G-quartets
  64. Paraneoplastic neurological degenerations: keys to tumour immunity
  65. Paraneoplastic Neurologic Disorders
  66. Memory, Synaptic Translation, and…Prions?
  67. Paraneoplastic Syndromes Involving the Nervous System
  68. Observing the invisible: successful tumor immunity in humans
  69. RNA Logic in Time and Space
  70. Fragile X Mental Retardation Protein Targets G Quartet mRNAs Important for Neuronal Function
  71. Microarray Identification of FMRP-Associated Brain mRNAs and Altered mRNA Translational Profiles in Fragile X Syndrome
  72. PARANEOPLASTICNEUROLOGICDISEASEANTIGENS: RNA-Binding Proteins and Signaling Proteins in Neuronal Degeneration
  73. The splice of life: Alternative splicing and neurological disease
  74. cdr2-Specific CTLs are detected in the blood of all patients with paraneoplastic cerebellar degeneration analyzed
  75. cdr2‐Specific CTLs are detected in the blood of all patients with paraneoplastic cerebellar degeneration analyzed
  76. Involvement of the TRAP220 Component of the TRAP/SMCC Coactivator Complex in Embryonic Development and Thyroid Hormone Action
  77. Sequence-Specific RNA Binding by a Nova KH Domain
  78. Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration
  79. Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration
  80. The Importance of Defining the Paraneoplastic Neurologic Disorders
  81. Immunologic Complexity in Neurons
  82. Tumor-specific killer cells in paraneoplastic cerebellar degeneration
  83. β-NAP, a cerebellar degeneration antigen, is a neuron-specific vesicle coat protein
  84. The polymerase chain reaction: Application to nervous system disease
  85. Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system
  86. The neuronal nuclear antigen recognized by the human anti-Ri autoantibody is expressed in central but not peripheral nervous system neurons